Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation
Adequacy of study:
other information

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: 92/69/EWG, B.6 (Meerschweinchen-Maximierungstest (GPMT)); OECD 406
GLP compliance:
yes

In vivo test system

Test animals

Species:
other: gpg, Dunkin-Hartley Crl:(HA)BR

Study design: in vivo (non-LLNA)

Induction
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) Intradermale Injektionen:

Substanz bei der Konzentration von 1 % (g/g) in

0,9 % NaCl.

b) Epidermale Applikation:

Substanz bei der Konzentration von 10 % (g/g) in

0,9 % NaCl.

"ENGLISH"

a) Intradermal injections:

Substance at the concentration of 1 % (g/g) in

0.9 % NaCl.

b) Epidermal application:

Substance at the concentration of 10 % (g/g) in

0.9 % NaCl.

Concentration of test material and vehicle used for each challenge:
Epidermale Applikation: Substanz bei der Konzentration von
10 % (g/g) in 0,9 % NaCl.

"ENGLISH"

Epidermal application: substance at the concentration of

10 % (g/g) in 0.9 % NaCl.
Challenge
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) Intradermale Injektionen:

Substanz bei der Konzentration von 1 % (g/g) in

0,9 % NaCl.

b) Epidermale Applikation:

Substanz bei der Konzentration von 10 % (g/g) in

0,9 % NaCl.

"ENGLISH"

a) Intradermal injections:

Substance at the concentration of 1 % (g/g) in

0.9 % NaCl.

b) Epidermal application:

Substance at the concentration of 10 % (g/g) in

0.9 % NaCl.

Concentration of test material and vehicle used for each challenge:
Epidermale Applikation: Substanz bei der Konzentration von
10 % (g/g) in 0,9 % NaCl.

"ENGLISH"

Epidermal application: substance at the concentration of

10 % (g/g) in 0.9 % NaCl.
No. of animals per dose:
Number of animals in test group: 20
Number of animals in negative control group: 10

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10 %
No. with + reactions:
15
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10 %. No with. + reactions: 15.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10 %
No. with + reactions:
19
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10 %. No with. + reactions: 19.0. Total no. in groups: 20.0.
Reading:
rechallenge
Hours after challenge:
24
Group:
negative control
Dose level:
10 %
No. with + reactions:
3
Total no. in group:
10
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 10 %. No with. + reactions: 3.0. Total no. in groups: 10.0.

Any other information on results incl. tables

Maximum concentration not causing irritating effects in preliminary test: 10 %

Signs of irritation during induction:
Mit intradermaler Injektion am Tag 1 (Konzentration

gewählt nach den Ergebnissen von den Vorversuchen).

Mit epidermaler Applikation der Substanz am Tag 8 (während
48 Stunden).

"ENGLISH"

With intradermal injection on day 1 (concentration selected
according to the results of the pretests).

With epidermal application of the substance on day 8 (during
48 hours).

Evidence of sensitisation of each challenge concentration:
Die Substanz verursacht verzögerte
Kontaktüberempfindlichkeit in 15/20 (75 %) der Tiere.

"ENGLISH"

The substance causes delayed contact hypersensitivity in
15/20 (75 %) of the animals.

Other observations:
Wegen der Substanz, wurde eine gelbliche Verfärbung der
behandelten Körperstelle in allen Tieren beider Gruppen
beobachtet. Es könnte einen möglichen getrennten oder
gemäßigten Erythema (Grad 1 oder 2) in einigen von den
Tieren am 24-stündigen Messwert verdeckt haben.

Eine Trockenheit der Haut wurde in 3/10 der Tiere der
Kontrollgruppe am 48-stündigen Messwert beobachtet.

Manchmal ist die Trockenheit der Haut mit Krusten und/oder
Ödemen verbunden. Die Trockenheit der Haut wurde in 16/20
der Tiere der behandelten Gruppe am 48-stündigen Messwert
beobachtet.



"ENGLISH"

Due to the substance, a yellowish discoloration of the
treated area of the body was observed in all of the animals
from both of the groups. It could have hidden a possible
separate or moderate erythema (grade 1 or 2) in some of the
animals at the 24-h measurement value.

Dryness of the skin was observed in 3/10 of the animals from
the control group at the 48-h measurement value. The dryness
of the skin is sometimes associated with scabs and/or
oedemas. The dryness of the skin was observed in 16/20 of
the animals from the treated group at the 48-h measurement
value.

Applicant's summary and conclusion

Interpretation of results:
other: irritant